Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano it
CORDIS - Risultati della ricerca dell’UE
CORDIS
Contenuto archiviato il 2024-05-14

Aging vision: Crystallins, visual acuity and cataract

Obiettivo

Objectives:
To identify the crystallin protein interaction sites involved in the aggregation that leads to cataract with the aim of designing small molecules or mimetics that block aggregation.

One of the hallmarks of aging is disease due cellular instability, the result of damage to macromolecular components. The most common of such diseases is cataract. Cataract is the most frequent cause of blindness in man and occurs inevitably with age, about 50% of the people 70 years of age suffer from significant loss of vision due to cataract. The high incidence of cataract results from one of the unusual properties of the lens: its mature fibre cells are incapable of macromolecular synthesis and damaged components cannot be replaced. For transparency, the lens depends on the short range interaction of its highly abundant structural proteins, making the lens particularly sensitive to protein misassembly. The built-in chaperone of the lens, alpha-crystallin, prevents aggregation of unfolding crystallins. The present theory is that cataract is irreversibly initiated, once the chaperone capacity of alpha-crystallin is exhausted. It is the objective of this RTD-project to determine the interaction sites through which the unfolding bˆta- and lacet-crystallins aggregate. The definition of such sites then allows the design of compounds that interact with these sites to prevent misassembly and thereby prevent or delay cataract.

To that end a combination of molecular biological, biochemical, cell biological and biophysical techniques will be used to determine
- the chaperone capacity of alpha-crystallin towards other human crystallins;
- the stability of the various human crystallins and the effect of post-translational modification (clipping, oxidation) there on the interaction between human crystallins;
- the structure of human crystallin (assemblies) Together the results should pinpoint the crystallin(s) most likely to initiate the cataractogenic process and the structural elements most likely to serve as interaction sites of structured unfolding intermediates.

In vivo, crystallin synthesis is regulated by ocular growth factors. Aberration in ocular growth factors, as a result of systemic disease or prolonged treatment with medication, could thus change the balance between alpha-crystallin and the bˆta- and lacet-crystallin and increase the likelihood of cataract. In vitro differentiating lens cultures will be used to determine the effect of growth factors in alpha, bˆta and lacet-crystallin synthesis, while the effect of changing the ratio of alpha to bˆta and lacet-crystallin on the likelihood of cataractogenesis will be assessed in transgenic mice strains. The transparency of the eye lens is the result of a fine tuning of interactions at different levels of organization. It is the aim of this RTD-project to determine how these interactions are disturbed and how misassembled proteins in the lens can be rescued before irreversible pathological changes occur. Keywords: cataract, lens, crystallins, protein aggregation.

Campo scientifico (EuroSciVoc)

CORDIS classifica i progetti con EuroSciVoc, una tassonomia multilingue dei campi scientifici, attraverso un processo semi-automatico basato su tecniche NLP. Cfr.: Il Vocabolario Scientifico Europeo.

È necessario effettuare l’accesso o registrarsi per utilizzare questa funzione

Programma(i)

Programmi di finanziamento pluriennali che definiscono le priorità dell’UE in materia di ricerca e innovazione.

Argomento(i)

Gli inviti a presentare proposte sono suddivisi per argomenti. Un argomento definisce un’area o un tema specifico per il quale i candidati possono presentare proposte. La descrizione di un argomento comprende il suo ambito specifico e l’impatto previsto del progetto finanziato.

Invito a presentare proposte

Procedura per invitare i candidati a presentare proposte di progetti, con l’obiettivo di ricevere finanziamenti dall’UE.

Dati non disponibili

Meccanismo di finanziamento

Meccanismo di finanziamento (o «Tipo di azione») all’interno di un programma con caratteristiche comuni. Specifica: l’ambito di ciò che viene finanziato; il tasso di rimborso; i criteri di valutazione specifici per qualificarsi per il finanziamento; l’uso di forme semplificate di costi come gli importi forfettari.

CSC - Cost-sharing contracts

Coordinatore

Katholieke Universiteit Nijmegen - Stichting Katholieke Universiteit
Contributo UE
Nessun dato
Indirizzo
1,Toernooiveld
6525 ED Nijmegen
Paesi Bassi

Mostra sulla mappa

Costo totale

I costi totali sostenuti dall’organizzazione per partecipare al progetto, compresi i costi diretti e indiretti. Questo importo è un sottoinsieme del bilancio complessivo del progetto.

Nessun dato

Partecipanti (3)

Il mio fascicolo 0 0